Teleflex (TFX) Liabilities and Shareholders Equity (2009 - 2026)
Teleflex's (TFX) quarterly Liabilities and Shareholders Equity came in at $6.8 billion in Q1 2026, down 5.31% YoY from $7.2 billion in Q1 2025, and down 2.36% on a QoQ basis from $6.9 billion in Q4 2025.
Teleflex (TFX) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
Teleflex (TFX) has 18 years of Liabilities and Shareholders Equity data on file, last reported at $6.8 billion in Q1 2026.
- Quarterly Liabilities and Shareholders Equity fell 5.31% year-over-year to $6.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.0 billion (down 0.73% YoY) and the FY2025 annual result came in at $6.9 billion, down 2.12% from the prior year.
- Liabilities and Shareholders Equity retreated to $6.8 billion in Q1 2026, from $6.9 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $7.9 billion in Q3 2025 to a low of $6.7 billion in Q2 2022.
- A 5-year average of $7.2 billion and a median of $7.1 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
- Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity advanced 10.88% — and 2024, when it declined 5.77%.
- Tracing TFX's Liabilities and Shareholders Equity over 5 years: stood at $6.9 billion in 2022, then gained by 8.73% to $7.5 billion in 2023, then fell by 5.77% to $7.1 billion in 2024, then decreased by 2.12% to $6.9 billion in 2025, then slipped by 2.36% to $6.8 billion in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $6.8 billion (Q1 2026), $6.9 billion (Q4 2025), and $7.9 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 20.88 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 50.73 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 31.10 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 8.97 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 39.35 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 4.08 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 14.24 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 12.48 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 19.79 Bn |
| 10 | Teleflex | 6.03 Bn | 5.73 Bn | 331.71 Mn | 6.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.79 Bn |
| Mar 31, 2026 | 6.78 Bn |
| Dec 31, 2025 | 6.95 Bn |
| Sep 28, 2025 | 7.87 Bn |
| Jun 29, 2025 | 7.38 Bn |
| Mar 30, 2025 | 7.16 Bn |
| Dec 31, 2024 | 7.10 Bn |
| Sep 29, 2024 | 7.49 Bn |
| Jun 30, 2024 | 7.44 Bn |
| Mar 31, 2024 | 7.48 Bn |
| Dec 31, 2023 | 7.53 Bn |
| Oct 1, 2023 | 7.49 Bn |
| Jul 2, 2023 | 6.90 Bn |
| Apr 2, 2023 | 6.92 Bn |
| Dec 31, 2022 | 6.93 Bn |
| Sep 25, 2022 | 6.76 Bn |
| Jun 26, 2022 | 6.73 Bn |
| Mar 27, 2022 | 6.87 Bn |
| Dec 31, 2021 | 6.87 Bn |
| Sep 26, 2021 | 7.04 Bn |